<DOC>
	<DOCNO>NCT00285051</DOCNO>
	<brief_summary>Patients treat 2 consecutive chemo cycle study drug one placebo . In addition , patient receive injection chemo , either ondansetron ( receive placebo inhalation ) normal saline ) receive active study drug . They take study medication 3 day , 4 time daily fill VAS score dos . Patients give rescue medication dose .</brief_summary>
	<brief_title>Comparison Delta-8-THC Ondansetron Prevention Acute Nausea From Moderately Emetogenic Chemotherapy</brief_title>
	<detailed_description>The study compare use inhale delata-8-THC prevention nausea vomitting patient treat moderately emetogenic chemotherapy , patient continue use 3 day afterward . Patients give rescue medication fill VAS scale nausea , pain , appetite dizziness . Patients treat 2 cycle , one cycle receive active drug ( one 2 dos ) placebo . Patients receive placebo receive ondansetron injection chemo patient receive active drug receive normal saline injection . Patients take drug 4 time daily 3 day . The patient return clinic visit 24-48 hour 4 day . Patients bring urine sample measure metabolite . Patients give diary monitor dose side effect well concomitant medication . The study conduct 2 - 3 center . There 108 patient enrol 27 4 group : Group 1 cycle 1 - Placebo cycle 2 - 300 mcg delta-8-THC per dose Group 2 cycle 1 - Placebo cycle 2 - 600 mcg delta-8-THC per dose Group 3 cycle 1 - 300 mcg delta-8-THC per doseGroup cycle 2 - Placebo Group 4 cycle 1 - 600 mcg delta-8-THC per dose cycle 2 - placebo</detailed_description>
	<mesh_term>Nausea</mesh_term>
	<mesh_term>Emetics</mesh_term>
	<mesh_term>Ondansetron</mesh_term>
	<criteria>Inclusion criterion : Signed informed consent Man woman 18 85 year age Patients receive least 2 cycle moderately emetogenic chemotherapy Patients cognitively intact Performance Status 60 % great Karnofsky Scale Negative pregnancy test screen visit female childbearing potential Use appropriate contraceptive method females childbearing potential treatment ( e.g . hormonal contraception , intrauterine device [ IUD ] ) A history psychiatric illness . A history asthma chronic respiratory illness . Subjects , judgment investigator , likely noncompliant uncooperative study . Serious illness asthma , diabetes mellitus , active peptic ulcer disease , infection , cardiovascular disease disease may affect oucome parameter study Abnormal liver function test ( ALT , AST AP &gt; 2.5 x upper normal limit ) Abnormal renal function ( e.g . serum creatinine &gt; 2 x upper normal limit ) Abnormal pulmonary function test judgment investigator incompatible inhalation study drug Known intolerance/hypersensitivity study drug ( THC , ondansetron dexamethasone ) drug similar chemical structure pharmacological profile History addiction alcohol drug Existing intended pregnancy lactation Participation another clinical trial within last 30 day , simultaneous participation another clinical trial , previous participation trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>February 2007</verification_date>
	<keyword>emesis , nausea ,</keyword>
</DOC>